Seven Fleet Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.44M Sell
24,066
-4,760
-17% -$1.04M 0.87% 19
2026
Q2
$7.06M Buy
28,826
+14,771
+105% +$3.2M 1.16% 20
2026
Q1
$2.38M Buy
14,055
+1,100
+8% +$190K 0.75% 35
2025
Q4
$2.37M Buy
+12,955
New +$1.81M 1.6% 10

Other funds holding AXSM

Seven Fleet Capital Management's AXSM Position: Q3 2026 in Review

Seven Fleet Capital Management reduced its Axsome Therapeutics (AXSM) stake by 17% in Q3 2026, selling an estimated $1.04M and leaving 24,066 shares worth $4.44M. The position accounts for 0.87% of the portfolio, ranked #19.

Seven Fleet Capital Management first reported a position in AXSM in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.06M in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Seven Fleet Capital Management held 24,066 shares of Axsome Therapeutics worth $4.44M as of Q3 2026.
  • Seven Fleet Capital Management sold 4,760 Axsome Therapeutics shares in Q3 2026, an estimated $1.04M.
  • Axsome Therapeutics made up 0.87% of Seven Fleet Capital Management's portfolio in Q3 2026, its #19 holding.
  • Seven Fleet Capital Management first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Seven Fleet Capital Management's Axsome Therapeutics position peaked at $7.06M in Q2 2026.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Seven Fleet Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.